Atherosclerosis Clinical Trials in Torrance, California

3 studies are recruiting for atherosclerosis in Torrance, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

    This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, who are receiving background therapy for cardiovascular (CV) risk factors management.

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
    Locations
    40 in total
    Run by
    Beijing Inno Medicine Co., Ltd.

    See if you can join NCT07521007 on ClinicalTrials.gov

  2. A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

    Lipoprotein(a), also known as Lp(a), is a protein that carries cholesterol and proteins in your blood. People with high Lp(a) have a higher risk for heart disease. The main purpose of the study is to investigate how lepodisiran, compared to a placebo, affects the amount and type of plaque in the he…

    Stage
    Phase 3
    Ages
    45 to 80
    Site
    Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
    Locations
    58 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07613294 on ClinicalTrials.gov

  3. Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

    A multi-center, randomized, double-blind, placebo-controlled, parallel-group phase IV Study evaluating the effects of tirzepatide on atherosclerotic plaque progression assessed by coronary computed tomography angiography (CCTA) in participants with a diagnosis of type II Diabetes (T2DM) and atheros…

    Stage
    Phase 4
    Ages
    40 to 80
    Site
    Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), Torrance, California
    Run by
    Matthew J. Budoff

    See if you can join NCT05708859 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.